Literature DB >> 20968130

Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.

Piret Veerus1, Marc Arbyn, Camilla Amati, Baili Paolo.   

Abstract

BACKGROUND: The objective of the EUROCHIP project in Estonia was to describe the organized cervical cancer screening program started in 2006 (after pilot studies in 2003-2005), to compare its performance with opportunistic screening, and to define priorities for improvement of the program.
METHODS: Population data was retrieved from Statistics Estonia, data about performed Pap-smear tests within the screening program from the Estonian Cancer Society and from clinics and labs participating in the program, data about Pap-smear tests outside the screening program from the Estonian Health Insurance Fund, and data about cancer incidence and mortality from the Estonian Cancer Registry database.
RESULTS: During the first year after implementing the nationwide cervical cancer screening program in Estonia, the number of tests outside the organized program remained high. Within the organized program, the number of Pap-tests in different age groups increased with age except for the oldest age group while population coverage with Pap-tests outside the organized screening program decreased with age. The number of cervical cancer cases at early stages increased after implementation of organized screening. The time-frame does not permit to draw any definitive conclusions.
CONCLUSIONS: Implementation of organized cervical cancer screening did not decrease the volume of opportunistic screening. The factors influencing attendance in the organized cervical cancer screening program in different age groups should be studied further. Moreover, a central cancer screening registry without restrictive data protection legislation would improve data collection and enable to evaluate performance of the program on a regular basis.

Entities:  

Mesh:

Year:  2010        PMID: 20968130     DOI: 10.1177/030089161009600403

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.

Authors:  Mariana Oliveira; Bárbara Peleteiro; Nuno Lunet
Journal:  Eur J Public Health       Date:  2013-06-20       Impact factor: 3.367

2.  Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.

Authors:  Alice Kivistik; Katrin Lang; Paolo Baili; Ahti Anttila; Piret Veerus
Journal:  BMC Womens Health       Date:  2011-09-28       Impact factor: 2.809

3.  Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination.

Authors:  Maria G Cappelli; Francesca Fortunato; Silvio Tafuri; Sara Boccalini; Paolo Bonanni; Rosa Prato; Domenico Martinelli
Journal:  Eur J Cancer Care (Engl)       Date:  2018-09-04       Impact factor: 2.520

4.  Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?

Authors:  Mindaugas Stankūnas; Kersti Pärna; Anna Tisler; Anda Ķīvīte-Urtāne; Una Kojalo; Jana Zodzika; Nicholas Baltzer; Jan Nygard; Mari Nygard; Anneli Uuskula
Journal:  Acta Med Litu       Date:  2022-06-29

5.  The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia.

Authors:  Anneli Uusküla; Andres Müürsepp; Kosuke Kawai; Mait Raag; Mikk Jürisson; Matthew Pillsbury
Journal:  BMC Infect Dis       Date:  2013-07-03       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.